NCBiotech News

Eastern North Carolina leaders are investing in the region’s growing entrepreneurial community as sponsors of NCBiotech's NC BIONEER Venture Challenge

Durham-based Mycovia Pharmaceuticals has received its first product approval from the FDA -- for VIVJOA, an oral antifungal capsule for treating recurrent vaginal yeast infections in women who have no reproductive capacity.

BASF has cut the ribbon on a 5,500-square-foot center dedicated to promoting sustainable agriculture, which is now open to the public in the heart of the Research Triangle.

Flush with more than $40 million in capital, Triad integrated research organization Javara says it’s getting ready to “revolutionize” the quality of clinical trials and, ultimately, patient outcomes.

Morrisville-based Heat Biologics will become NightHawk Biosciences (NYSE American: NHWK) on May 3.

With Gov. Roy Cooper's recent announcement on the extension of the Longleaf Commitment community college grant program, more low- and moderate-income North Carolinians can afford to get training for the fast-growing number of great jobs in the life sciences.

The Wake Forest Institute of Regenerative Medicine and the RegenMed Development Organization, both in Winston-Salem, are partnering with Houston's Axiom Space, developer of the world’s first commercial space station, to advance regenerative medicine manufacturing in space.

A whopping $300 million in federal funding is in the offing for small businesses developing innovative technologies -- and this May 3 seminar is going to teach you how to access it.

Carolina Liquid Chemistries Corp. of Greensboro has signed a semi-exclusive agreement to distribute a portable chemistry analyzer for the U.S. veterinary market.

MOLTOX, a family-owned pioneer in developing standardized genetic toxicology test products, just keeps getting stronger after 36 years in business from unlikely headquarters in the North Carolina mountain community of Boone.

UNC has launched a program to bring more young people in every corner of North Carolina into a COVID-enabled initiative to connect with the possibilities now open In the life sciences.

Pittsboro-based startup Propella Therapeutics is looking to China as a market for its new osteoarthritis treatment.

Durham-based Bioventus is buying fellow orthopedic device maker CartiHeal following FDA approval of its Agili-C cartilage repair implant.

If you’re an executive or director of one of North Carolina’s 790 life sciences companies, now’s the time to set aside May 4 on your corporate calendar to attend the NACD forum at NCBiotech in RTP "Leading from the Boardroom: Navigating the Life Science Boardroom."

Alamance Community College’s role in regional workforce development continues to grow, as it graduates over one-fourth of the state’s community college biotechnology talent.